Icela Palma-Lara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Icela Palma-Lara has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Adolfo López-Ornelas
División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico
1 shared publication Alejandra Contreras-Ramos
Laboratorio de Investigación de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez (HIMFG), Ciudad de México, Mexico
1 shared publicationAna Lilia Sandoval Mejía
Servicio de Oncología Quirúrgica, Servicio de Patología, Hospital de Gineco-Obstetricia No.3, IMSS, Centro Médico La Raza, Ciudad de México, Mexico
1 shared publicationAna María Espinosa-García
Servicio de Farmacología Clínica, Hospital General de México, Ciudad de México, Mexico
1 shared publication- Ana María Espinosa-García
Laboratorio de Farmacología Clínica, Hospital General de México, Ciudad de México 06720, Mexico
1 shared publication Ana Victoria De Alba González
Servicio de Oncología Quirúrgica, Servicio de Patología, Hospital de Gineco-Obstetricia No.3, IMSS, Centro Médico La Raza, Ciudad de México, Mexico
1 shared publication
Latest Publications
- Open Access
- 17 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8904
Potential Role of Protein Kinase FAM20C on the Brain in Raine Syndrome, an In Silico Analysis
FAM20C (family with sequence similarity 20, member C) is a serine/threonine-specific protein kinase that is ubiquitously expressed and mainly associated with biomineralization and phosphatemia regulation. It is mostly known due to pathogenic variants causing its deficiency, which results in Raine syndrome (RNS), a sclerosing bone dysplasia with hypophosphatemia. The phenotype is recognized by the skeletal features, which are related to hypophosphorylation of different FAM20C bone-target proteins. However, FAM20C has many targets, including brain proteins and the cerebrospinal fluid phosphoproteome. Individuals with RNS can have developmental delay, intellectual disability, seizures, and structural brain defects, but little is known about FAM20C brain-target-protein dysregulation or about a potential pathogenesis associated with neurologic features. In order to identify the potential FAM20C actions on the brain, an in silico analysis was conducted. Structural and functional defects reported in RNS were described; FAM20C targets and interactors were identified, including their brain expression. Gene ontology of molecular processes, function, and components was completed for these targets, as well as for potential involved signaling pathways and diseases. The BioGRID and Human Protein Atlas databases, the Gorilla tool, and the PANTHER and DisGeNET databases were used. Results show that genes with high expression in the brain are involved in cholesterol and lipoprotein processes, plus axo-dendritic transport and the neuron part. These results could highlight some proteins involved in the neurologic pathogenesis of RNS.
- 17 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8904
Open AccessPotential Role of Protein Kinase FAM20C on the Brain in Raine Syndrome, an In Silico Analysis
FAM20C (family with sequence similarity 20, member C) is a serine/threonine-specific protein kinase that is ubiquitously expressed and mainly associated with biomineralization and phosphatemia regulation. It is mostly known due to pathogenic variants causing its deficiency, which results in Raine syndrome (RNS), a sclerosing bone dysplasia with hypophosphatemia. The phenotype is recognized by the skeletal features, which are related to hypophosphorylation of different FAM20C bone-target proteins. However, FAM20C has many targets, including brain proteins and the cerebrospinal fluid phosphoproteome. Individuals with RNS can have developmental delay, intellectual disability, seizures, and structural brain defects, but little is known about FAM20C brain-target-protein dysregulation or about a potential pathogenesis associated with neurologic features. In order to identify the potential FAM20C actions on the brain, an in silico analysis was conducted. Structural and functional defects reported in RNS were described; FAM20C targets and interactors were identified, including their brain expression. Gene ontology of molecular processes, function, and components was completed for these targets, as well as for potential involved signaling pathways and diseases. The BioGRID and Human Protein Atlas databases, the Gorilla tool, and the PANTHER and DisGeNET databases were used. Results show that genes with high expression in the brain are involved in cholesterol and lipoprotein processes, plus axo-dendritic transport and the neuron part. These results could highlight some proteins involved in the neurologic pathogenesis of RNS.
- 1 May 2022
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 364 (5) , 583-594
NOTCH expression variability and relapse of breast cancer in high-risk groups
- 1 May 2022
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 364 (5) , 583-594
NOTCH expression variability and relapse of breast cancer in high-risk groups